Clinical trial to start tests on psychedelics for depression
Dr Vince Polito, a clinical psychologist and Senior Research Fellow at Macquarie University’s School of Psychological Sciences, is leading a clinical trial to test the
Proposal for assessing long COVID patients developed
International scientists have developed an assessment proposal aimed at clinicians and researchers to establish an individualised treatment protocol for long COVID patients. It is estimated
Featured Leader Q&A: Lance Kawaguchi, CEO of Cure Brain Cancer Foundation
Brain cancer is a disease that largely affects children, and is a complex condition to get around. Cure Brain Cancer Foundation’s newly-installed CEO Lance Kawaguchi
Cure Brain Cancer connects Australians to glioblastoma treatments
Cure Brain Cancer Foundation (CBCF), the leading charity for brain cancer research, awareness and advocacy in the region, has announced a partnership with the Global
NSW Health urges residents to get tested for HIV as states reopen
In the lead up to World AIDS Day, NSW Health is encouraging people across the state at risk of HIV to get tested. As NSW
New treatment available for Australians with leukaemia
From 1 December 2021, Australians with acute myeloid leukaemia (AML) will have access to a new treatment option on the Pharmaceutical Benefits Scheme (PBS). The
Funding boost for Fetal Alcohol Spectrum Disorder diagnosis and care
The diagnosis and treatment of children with Fetal Alcohol Spectrum Disorder (FASD) is set to be strengthened with the announcement of $3.68 million in funding
New treatment options for deadliest of cancers
A new targeted treatment for mutant proteins which can cause the deadliest of cancers in humans has been uncovered by scientists at the University of
Potential antivirals for COVID-19 revealed in large-scale drug analysis
Researchers at the Francis Crick Institute and the University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential
Latest Technique for Cancer Treatment
Its inventor, UQ Diamantina Institute’s Dr. Fiona Simpson, said it could be used to show how long antibodies stayed active in patients, or when antibodies
